EGFR and lung cancer: Athymic nude mice were injected with H1975 human lung cancer cells (5 × 106), expressing the EGFR T790M mutation which confers resistance to erlotinib (EGFR-TKI), in their flank and administered UA (25 mg/kg) via daily injection for 18 days.